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Abstract. The neural cell adhesion molecule NCAM 
is capable of mediating cell-cell adhesion via homo- 
philic interactions. In this study, three strategies have 
been combined to identify regions of NCAM that par- 
ticipate directly in NCAM-NCAM binding:  analysis of 
domain deletion mutations, mapping of epitopes of 
monoelonal antibodies, and use of synthetic peptides 
to inhibit NCAM activity. Studies on L cells trans- 
fected with NCAM mutant cDNAs using cell aggrega- 
tion and NCAM-covasphere binding assays indicate 
that the third immunoglobulin-like domain is involved 
in homophilic binding. The epitopes of four mono- 
clonal antibodies that have been previously shown to 
affect cell-cell adhesion mediated by NCAM were also 
mapped to domain 3. Overlapping hexapeptides were 
synthesized on plastic pins and assayed for binding 
with these monoclonal antibodies. One of them (PP) 
reacted specifically with the sequence KYSFNY.  Syn- 
thetic oligopeptides containing the PP epitope were 
potent and specific inhibitors of NCAM binding activ- 
ity. A  substratum containing immobilized peptide con- 
jugates also exhibited adhesiveness for neural retinal 
cells. Cell attachment was specifically inhibited by 
peptides that contained the PP-epitope and by anti- 
NCAM univalent antibodies. The shortest active pep- 
tide has the sequence KYSFNYDGSE, suggesting that 
this site is directly involved in NCAM homophilic 
interaction. 
C 
ELL-CELL adhesive  interactions  are important con- 
tributors to the establishment of form and pattern 
during development (for reviews,  see Rutishauser 
and Jessell,  1988; Takeichi, 1990; Reichardt and Tomaselli, 
1991). A basic understanding of these complex interactions 
ultimately requires the isolation of adhesion molecules and 
the characterization of  their mechanisms of action. The neu- 
ral cell adhesion molecule NCAM 1 was one of the first ad- 
hesion molecules to be detected (Rutishauser et al.,  1976; 
Brackenbury et al.,  1977),  isolated  (Thiery et al.,  1977), 
and characterized (Hoffman et al., 1982). NCAM is a rela- 
tively abundant glycoprotein  present on both neural and non- 
neural cells,  and is capable of mediating calcium-indepen- 
dent cell-cell adhesion (Rutishauser et al.,  1982). 
The structure of NCAM has been defined in considerable 
detail (Murray et al., 1986; Barthels et al., 1987; Cunning- 
ham et al., 1987; Barbas et ai., 1988; Barton et al., 1988). 
This large membrane-associated  glycoprotein  belongs to the 
Ig superfamily of recognition molecules (Williams and Bar- 
clay, 1988). Its extracellular domain consists of five contigu- 
ous  Ig-like  domains,  each with  characteristic intraehain 
disulfide loops.  NCAM is present in many polypeptide iso- 
1. Abbreviations used in this paper: EDC,  l-ethyl-3-(3-dimethylaminopro- 
pyl)carbodiimide hydrochtoride; KLH, keyhole limpet hemoeyanin; MBS, 
m-maleimidobenzoyl-N-hydroxysuccinimide ester; NCAM, neural cell ad- 
hesion molecule;  PCR, polymerase  chain reaction. 
forms that are generated by tissue-specific splicing of RNA 
species  derived from a  single copy gene (for review, see 
Walsh and Doherty, 1991). The three most abundant forms, 
NCAM-180,  NCAM-140, and  NCAM-120, have  similar 
amino-terminal extracellular domains but  truncated  car- 
boxyl-terminal domains. While NCAM-180 and NCAM-140 
are integral membrane proteins, NCAM-120 is attached to 
membranes via a glycosyl-phosphatidylinositol  anchor (He 
et al., 1986; Hemperley et al., 1986). NCAM is further di- 
versified by posttranslational modifications. A striking modi- 
fication is the ot-2,8-1inked polysialic  acid,  the amount of 
which is regulated during development and modulates cell- 
cell interactions  (for reviews,  see Edelman,  1983; Rutis- 
hauser,  1989). 
NCAM  appears  to participate  in cell-cell adhesion via 
homophilic interactions. The initial evidence for homophilic 
binding studies of lipid vesicles containing purified NCAM 
(Rutishauser  et al.,  1982; Hoff-man and Edelman, 1983). 
More recently, the transfection of NCAM eDNA into fibro- 
blasts to induce NCAM-dependent cell-cell binding (Edel- 
man et al., 1987; Pizzey et al., 1989) has further supported 
this hypothesis.  However, NCAM-mediated  adhesion may 
be more complex than a simple homophilic ligation.  It is 
known that NCAM also exhibits binding affinity for heparan 
sulfate (Cole et al., 1986b; Cole and Glaser,  1986), which 
can augment NCAM-mediated cell-cell binding  (Cole  et 
al.,  1986a). 
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ing activities,  it is valuable to identify the exact location of 
their respective functional sites and to elucidate the mecha- 
nism  of binding.  One  adhesion-dependent  region,  corre- 
sponding to the heparin binding domain, has been mapped 
to the second Ig-like domain (Cole et al.,  1986b; Frelinger 
and Rutishauser,  1986),  and more  recently  to  a  17-amino 
acid segment within this domain (Cole and Akeson,  1989; 
Reyes  et ai.,  1990).  However,  the  location  of homophilic 
binding sites has been only generally  defined.  On the basis 
of mAb mapping, a site has been proposed to reside within 
a region corresponding to domains 3  and 4  (Frelinger and 
Rutishauser,  1986; Cunningham et al.,  1987). To more pre- 
cisely define NCAM homophilic binding sites, we have used 
three different strategies,  including analysis of domain dele- 
tion mutants, mapping of mAb epitopes, and use of synthetic 
oligopeptides  to  inhibit  NCAM  homophilic  interaction. 
Results presented in this report suggest that a sequence of 10 
amino  acids  (KYSFNYDGSE)  located  in  domain  3  is 
directly  involved in NCAM homophilic binding. 
Materials and Methods 
Materials 
Prederivatized  plastic pins and polypropylene  trays were  obtained from 
Cambridge Research Biochemicais (Valley  Stream, NY). Active esters of 
9-fluorenylmethoxy-earbonyl  amino acids  were  obtained from MilliGen 
(Millipore Corp., Bedford,  MA), phenylacetamidomethyl  polystyrene  res- 
ins were from Applied Biosystems  Inc.  (Foster  City,  CA),  and t-butoxy- 
carbonyl amino acids were from IAF Biochemicals (Montreal, Quebec, 
Canada).  Covaspheres  were obtained from Duke Scientific  Corp.  (Palo 
Alto, CA).  l-Ethyl-3-(3-dimethylaminopropyl)carbodiimide  hydrochloride 
(EDC) and m-maleimidobenzoyl-N-hydroxysoccinimide  ester (MBS) were 
purchased from Pierce Chemical Co. (Rockford,  IL).  Other reagents used 
were of highest chemical grade. 
Construction of  Deletion Mutations in NCAM cDNA 
pEC1402 that contains the entire coding region of chick NCAM-140 eDNA 
(Edelman et al.,  1987) was kindly provided by Dr. B. Murray (University 
of California, Irvine, CA). A 1.8-kb HindIII fragment and a 2.8-kb EcoRI 
fragment were isolated from pEC1402 and inserted in pBluascript SKII(+) 
for deletion and DNA sequencing.  Deletions  were made using the con- 
venient restriction sites, such as EcoRI,  Psfl, NdeI, HindIII, and Tthlll I 
(Fig.  1). To delete the heparin-binding site in domain 2 (A2-NCAM),  the 
2.8-kb EcoRI fragment was digested with PstI and HindIH to release a 0.7- 
kb fragment that was used to replace the 0.9-kb EcoRI-to-HindIII frag- 
ment in the pEC1402 vector.  To delete domain 4 (A4-NCAM),  the eDNA 
was digested with Nde I, filled in with Klenow fragment to generate blunt 
end, and then ligated to the EcoRI site using EcoRI linker. To delete domain 
5 (A5-NCAM),  the eDNA was digested with Tthlll I, filled in to generate 
blunt end, and then ligated to the HindI~ site using HindIH linker.  Both 
A1-NCAM and A3-NCAM  were constructed using the primers: 5'-GAA- 
TTCGCCAACGCTGATCTC-3'(I),  5'-ACATATG  TGC TC  TGC C~C - 
GC-3' (ID, and the M13 universal primer,  in polymerase chain reactions 
(PCR).  Primer I contained an EcoRI site at its 5' end and the polymerase 
chain reaction (PCR) product was used to replace the fragment upstream 
of the internal EcoRI site to construct A1-NCAM. Primer II contained the 
NdeI site at its 5' end and the PCR product was used to replace the EcoRI 
to  NdeI fragment to generate A3-NCAM.  All deletion mutations were 
verified by double-strand DNA sequencing (Chen and Seeburg,  1985) using 
the dideoxy chain termination method (Sanger et ai.,  1977).  The NCAM 
mutants were all cloned into the expression vector pEC, which used the SV- 
40 early promoter to drive NCAM expression. 
Cell Transformation 
Mouse L  (tk-) cells were  grown with ,~-MEM medium containing 10% 
FCS in 10-cm dishes until subconfhence. Cells were collected  and plated 
on 10-cm dishes (at 1:10  dilution) 1 d before transformation. The cells were 
Figure  1.  NCAM  deletion  mutant  constructs.  Deletion  mutants 
were constructed using wild-type eDNA  coding for NCAM-140. 
The resulting NCAM mutant products were schematically repre- 
sented, with the five homologous Ig-like domains shown by stip- 
ples, the transmembrane region by a solid bar, and the cytoplasmic 
domain by stripes. The numbering of amino acids is in accordance 
with Cunningham et al. (1987). Numbers adjacent to each deletion 
indicate amino acids flanking the deletion and present in the mutant 
protein. Mutant cDNAs were cloned into the pEC vector for trans- 
fection into L cells. NCAM eDNA and the restriction sites used in 
the construction of these deletion mutations are shown at the bot- 
tom. The two arrows indicate the complementary sites of the two 
primers used to generate PCR fragments. 
transfected with 20/~g of NCAM plasmid DNA using the calcium phosphate 
precipitation method (Sambrook et al.,  1989).  2 d after transformation, 
cells expressing NCAM were selected with a rabbit anti-NCAM polyclonal 
antibody using the cell panning method (Wysocki and Sato,  1978). Micro- 
biological-grade  Pctri dishes (10 cm diam) were coated with 10 ml of rabbit 
anti-NCAM IgG at 5 ~tg/ml for 40 rain and washed five times with PBS and 
once with 1% fetal bovine serum in PBS. Cell suspension (3 ml) was added 
to each dish and allowed to adhere to the IgG--coated surface for 60 rain 
at 4~  The unbound  cells were removed by gentle washing, while the bound 
cells were transferred  to a tissue culture-grade dish. 2 wk later the cells 
were selected again using the same procedure to isolate the stable NCAM- 
expressing cells. The bound cells were further subcloned in 96-well dishes 
using the limited dilution method. 
Immunofluorescence Staining of  NCAM 
Cells were seeded sparsely on coverslips 24 h before staining.  Cells were 
washed once with PBS and then fixed with 100% methanol at -20~  for 
2 min. Coverslips  were incubated for 5 min at room temperature with a 
blocking solution of 1% BSA in PBS. Coverslips were then incubated with 
100 ~1 of 1% BSA and 5/~g/ml rabbit anti-NCAM polyclonai  antibody for 
1 h. The cells were then washed five times with PBS before incubation with 
biotinylated  goat anti-rabbit  IgG for 1 h. Cells were again washed five times 
and then incubated with streptavidin-conjugated  Texas Red. Slides were ob- 
served using a Wild Leitz Orthoplan fluorescence microscope (Wild Leitz, 
Toronto,  Canada).  When  cells  were  stained  with  anti-NCAM  mAb, 
rhodamine-conjugated,  afffinity-purified F(ab')2  fragments  of goat  anti- 
mouse IgG were used as the second antibody. 
Eiectrophoresis and Immunoblotting 
Cells (1  ￿  106) were plated on dishes 24 h before harvest. Cells were col- 
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for 3 min, the cell pellet was washed once with PBS and lysed in a solution 
containing 2% SDS, 8 M urea, 10 mM Tris (pH 8.0),  I mM EDTA, 2 mM 
PMSF, 5 #g/ml trypsin inhibitor, 10 t~g/rnl aprotinin, and 10/~g/ml DNase 
I. Undissolved material was removed by centrifugation at 10,000  rpm for 
2 rain. Aliquots of the soluble fraction (equivalent to ,~2 x  10  ~ cells) were 
electrophoresed on a 7.5% SDS-polyacrylamide gel (Laemmli, 1970) and 
then electroblotted onto nitrocellulose filter (Towbin et al., 1979). The blot 
was indirectly stained with a rabbit polyclonal antiserum directed against 
NCAM and an alkaline phosphatase-conjugated second antibody. 
Quantification Of  NCAM Expression 
in Transformants 
The relative levels of NCAM expression in L cell transformants were deter- 
mined by using an ELISA as described by Doherty et al. (1989).  Approxi- 
mately 20,000 cells were seeded in 96-well plates and grown for 18 h. After 
removal of the culture media, cells were fixed with preohilled methanol 
(-20"C) for 10-15 rain. The wells were incubated with 1% BSA for60 rain 
to block nonspecific protein-binding sites. Anti-NCAM mAb (100 #1 at 
2 t~g/ml) was added to the wells and incubated at 20"C for 60 rain. After 
three washes with 1% BSA in PBS, the cells were further incubated with 
100 t~l of anti-mouse horse peroxidase-conjngated  F(ab32 (1:1,000 dilution) 
for 60 rain. Cultures were washed four times with PBS and twice with wa- 
ter. Color developmem was carried out by incubation with 100 t~l of 0.05 % 
2,2:azino-bis(3-ethylbcnz-thiazoline-6-sulfonic acid) and 0.02%  (eel/eel) 
H202  in citric acid buffer for 60 min. The OD at 405 nm was monitored 
with  a  Titertek  Mulfiscan microtiter plate reader (Flow  Laboratories, 
Toronto, Canada). 
Solid-Phase Peptide Synthesis 
Overlapping hexapeptides were synthesized on polyethylene pins as de- 
scribed by (k-ysen et ni. (1987).  The peptides were assembled on the pins 
in the C to N terminus direction using 9-fluorenytmethoxy-carbonyl  amino 
acids (Carpino, 1987).  Larger quantifies of oligopeptides were synthesized 
by classical solid-phase methods (Erickson and Merrifield, 1976; Steward 
and Young, 1984) on phenylacetoamidomethyl  resin supports using t-butoxy- 
carbonyl amino acids. Synthesis was carried out on an automated peptide 
synthesizer (model 430; Applied Biosystems, Inc.). Side chain protecting 
groups were removed and the peptides were cleaved from the support using 
anhydrous hydrogen fluoride. The peptides were extracted from the resin 
with  10%  aqueous acetic acid,  lyophilized, and analyzed for purity by 
revers~phase HPLC and for composition by amino acid analysis. Peptides 
were  desalted  on  a  P2  gel  filtration  column  equilibrated  in  0.1  M 
NI~HCO3 and lyophilized. 
ELISA for Peptide-conjugated Plastic Pins 
Peptides coupled to solid-support plastic pins were incubated in a blocking 
solution containln¢ 2% (wt/vol) BSA, 0.1% (eel/eel) Tween-20, and 0.05% 
(wt/vol) sodium azide in PBS for 30 rain at room temperature with gentle 
reeking. The pins were then incubated overnight in mierotiter plates con- 
tainin~ 130 ~l per well of mAb (2-5 ~g/ml in blocking solution) at 4"C. 
They were washed four times, 10 rain each, in a dish pan containing PBS 
and 0.05 % Tween-20. This was followed by incubation for 1 h in microtiter 
wells containin  S 130 #1 of a goat anti-mouse IgG antibody conjugated with 
peroxidase or alkaline phospbatase on a platform shaker. Pins were washed 
four times, 10 rain each, and the once in the substrate buffer. The pins were 
then transferred to a mierotiter plate containing 100 #l of substrate per well. 
Color development  was monitored at 405 nm using a microtiter plate reader. 
Aggregation of  Brain Vesicles 
Brain vesicles were prepared from 14-d-old chick embryos as described 
ffI~  et ni., 1982),  and their rate  of ~tion  was determined in  a 
rotation-suspension assay using a particle  counter (Rtltishauser  et al., 
1985).  Briefly,  fresh  membrane vesicles  suspended in  PBS were rotated  at 
90 rpm on a rotary  shaker  at  25°C, with  aliquots  taken  at  0, 3, and 6 rain. 
The aliquots  were fixed  in I% glutaraldehyde  before  counting  with  a ZBI 
analyzer (Coulter  Electronics,  Hialeah,  FL). 
Cell Aggregation Assay 
NCAM Ur~msformants  were plated on dishes 20 h before assay to ensure that 
they were in their exponential growth phase. Aggregation assay was carried 
out according to Pizzey et al. (1989) with minor modifications. Cells were 
collected in PBS containing 2 mM EDTA and centrifuged at 500 rpm for 
5 rain. Ceils were washed once with PBS and a suspension of single cells 
('~3  x  10  ~ cells/rrd) was prepared in ct-MEM  medium containing  1% 
FBS. 200-t~l aliquots were incubated in plastic tubes at 37°C for 40 nan, 
followed by four cycles of up and down rotation on a Labquake shaker (8 
cycles/rain) to ensure sampling from a  homogeneous population. Single 
cells were counted using a hemacytometer. 
When neural  retinal  cells  were used  in  this  assay,  cells  were  isolated  from 
10-d-old  chick  embryos using  the  method  ofBrackenbury et  al.  (1981).  Reti- 
nai cells  were dissociated  in Mg2+/Ca2+-free HBSS containing 0.005  % 
(wt/vol)  trypsin  and 2 mM  EDTA. The cells  were then  centrifuged  through 
a step  gradient  of  BSA before  resuspension  at •5 x  I06 cells/ml  in PBS 
containing  50  #g/ml  of  DNase I.  0.2-ml  aliquots  were  rotated  on  a  platform 
shaker  at  150 rpm at  37°C and  the  percentage  of  cell  aggregation  was  moni- 
tored  at regular  time  intervals. 
Binding of NCAM-conjugated Covaspheres to Cells 
Green or red MX covaspheres (100/~1) were briefly sonicated before the ad- 
dition of 20 #g of chick brain NCAM and the final volume was adjusted 
to 200 p.I with PBS. ARer incubation at room temperature for 75 rain, the 
covaspheres were centrifuged at 10,000 g for 10 rain at 4°C. The pellet was 
resuspended  in  I  ml  of  PBS containing  1% BSA to  block  the  unreactive  sites 
on the covaspheres.  The covaspheres  were centrifuged  and rcsuspended in 
100/~l  PIGS.  To assay  for  the  ability  of  the  NCAM-covasphercs in  cell  bind- 
ing,  NCAM-transformcd cells  were seeded sparsely  on covcrslips  20 h be- 
fore  the assay.  In case  of neural  retinal  cells,  freshly  prepared cells  were 
allowed  to adhere to  coverslips  for  30 min at 37°C. Coverslips  were then 
washed once with PBS and incubated  with I00/zl  of  NCAM-covaspheres 
(at  1:20  dilution  of  stock)  for  30-40 rain  at  room temperature  on  a  platform 
shaker. After washing several times with PBS, ceils were observed using 
epifluorescence  microscopy. Cells with more than five covaspheres attached 
on the surface were scored as positive cells and generally 100-200 cells 
were scored in each experiment. 
Cell-Substratum Adhesion Assay 
The plastic surface of  Petri dishes was coated with nitrocellulose solubilized 
in  methanol,  according  to  the  method  of  Lagenaur and  Lemmon (1987),  and 
the dishes were air dried. P5 was conjugated to keyhole limpet hemocyanin 
(KLH) using EDC (Yamada et al., 1981). The 2-ml reaction mixture con- 
rained 4 nag P5 and 10 nag KLH and the reaction was carried out for a period 
of  4 h at  room temperature.  The P5-KLH conjugate  was separated  from the 
uncoupled peptide  on a P2 column. PIt (CEKYSFNYDGSE)  was con- 
jugated  to  KLH via  the  cys  residue  added  to  its  amino terminus  using  MBS 
(Lerner  et  al.,  1981).  Coupling was  carried  out  overnight  at  room tempera- 
ture  and  the  uncoupled peptidc  was removed by dialysis.  To allow  the  pep- 
tide  conjugates  to  adsorb  to  the  nitrocellulose  surface,  50-#I  aliquots  of  P5- 
or PII-KLH  000 /~g/ml) were placed on 1-cm-diam  spots previously 
marked on  the  plastic  surface  for 1.5  h. Excess binding  sites  were  blocked 
by 1% (wt/vol) BSA and the dish was washed three times with PBS. 
Retinal cells were isolated from day 10 chick embryos and resuspended 
in ieucine-free  medium containing 0.2 % (wt/vol) BSA. Cells were metabol- 
ically labeled with [3H]leucine  (25 #Ci/ml) for 2 h at 37°C. Labeled cells 
were washed with medium comaining 10%  F-'BS and 50-#1 atiquots were 
placed on the pcptide-KLH spots. Dishes were incubated for 2 h at 37°C 
for cell attachment. In competition experiments, 25-~,1 aliquots of competi- 
tor (2 mg/ml) were placed on the pcptide-KLH spots for 5 rain before the 
addition of the 25/~1 of labeled cells at twofold cell concentration. At the 
end of the incubation period, dishes were flooded with PBS to remove 
the unbound ceils, followed by three washes. Control spots with adsorbed 
KLH were included in each dish to monitor the consistency of the washing 
procedure and all assays were carried out in triplicate. The bound ceils were 
solubillzed  by rinsing each spot  twice with 50 #I of  2% (wt/vol) SDS and 
the combined lysed material was counted in a scintillation counter. 
Results 
Expression of  Deletion Mutants of NCAM 
in L Cell Transformants 
Our  strategy  to  identify  domains  that  contribute  to  the 
NCAM homophilic binding site was to express NCAM pro- 
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formants were collected and subjected to electrophoretic  analysis. 
Proteins were blotted onto nitrocellulose filter and immunostained 
using an anti-NCAM rabbit antiserum. Molecular weight standards 
are indicated on the left.  Molecular sizes of mutant NCAM pro- 
teins were estimated. Lane A, wild-type NCAM (sd form) with 135 
kD; lane B, A1-NCAM with 95 kD; lane C, A2-NCAM with 125 
kD; lane D, A3-NCAM with 94 kD;  lane E, A2,3-NCAM  with 
87 kD; lane F, A4-NCAM with  116 kD; and lane G, A5-NCAM 
with 85 kD. 
teins carrying deletion mutations and then determine which 
mutations would abolish NCAM homophilic interaction.  A 
series of deletion mutations was generated in the eDNA of 
NCAM-140 (Fig.  1). Transformation vectors carrying these 
mutant inserts were used to transfect L cells. Cotransforma- 
tion was initially performed using the pSVneo vector (South- 
ern and Berg,  1982) and G418-resistant colonies were iso- 
lated and cloned.  About 20%  of these colonies expressed 
NCAM,  with  a  transformation  efficiency of  '~1  ￿  10 -5. 
Cells were also transformed with the pEC vector without the 
NCAM eDNA insert to serve as controls. Since most of the 
NCAM-positive clones were not stable in their expression of 
NCAM, they required frequent reselection by the cell pan- 
ning  method  (Wysocki and  Sato,  1978).  Cells  expressing 
NCAM were selected by several cycles of cell panning on a 
substratum coated with rabbit anti-NCAM IgG, followed by 
subcloning in 96-well plates. Clonal lines that had been pas- 
saged for 8-10 wk were routinely reselected by cell panning 
for high  expression  cells.  Transformants expressing  non- 
functional NCAM mutants were more stable and did not re- 
quire frequent reselection. 
L cell transformants were subjected to immunoblot analy- 
sis to identify the form of NCAM expressed (Fig. 2).  The 
wild-type NCAM migrated as a broad band with an apparent 
molecular size of 135-140 kD, similar to what is expected 
for NCAM-140. The sizes of the other NCAM deletion mu- 
tants expressed in transformants were also in agreement with 
their predicted values. The relative levels of NCAM in trans- 
formed L cells were also quantified by ELISA and the results 
are summarized in Table I. All of the NCAM transformants 
showed a  five- to  eighffold higher  signal than the control 
transforrnant. Since NCAM was not detected in control cells 
by  immunoblot analysis,  the  weak  signals  obtained  with 
these cells probably represent nonspecific trapping of the an- 
tibody. To examine the cellular distribution of NCAM, trans- 
formed cells were fixed and immunostained with a rabbit an- 
Table L Expression of  NCAM in L Cell Transformants 
Relative level of NCAM  expression 
NCAM construct  (OD~) 
pEC  0.057  + 0.015 
Wild-type NCAM  0.269  + 0.015 
A1-NCAM  0.277 +  0.032 
A2-NCAM  0.261  + 0.026 
A3-NCAM  0.298  + 0.015 
A2,3-NCAM  0.394  5: 0.037 
A4-NCAM  0.371 5: 0.028 
A5-NCAM  0.429  5:0.011 
ELISA  was carried  out according  to the methods of Doherty  et al. (1989). Anti- 
NCAM mAbs  5E and 9A (Watanabe  et al., 1986) were used as primary  anti- 
bodies. Color  development  was carried out for 60 rain and the OD at 405 nm 
was read using a multititer plate reader. Values represent the mean •  SD of 
three separate  assays. 
tiserurn.  Most  of  the  cells  showed  strong  fluorescence 
labeling  associated  with  the  plasma  membrane  (Fig.  3). 
These data indicate that both wild-type and mutant NCAM 
proteins were transported properly to the plasma membrane 
of transformed cells and stably anchored there. 
Aggregation of Transformed Cells 
L cell transformants expressing wild-type NCAM exhibited 
a  mutual  adhesiveness in  culture,  giving rise  to  compact 
colonies with cell-cell contacts. On the other hand, control 
transformants retained the L cell morphology and rarely en- 
gaged in  cell-cell  contacts.  In cell  adhesion  assays,  with 
NCAM transformants subjected to rotation at 60-120 rpm, 
only small aggregates were formed with no significant differ- 
ence between NCAM-positive and control cells.  However, 
when cells were allowed to aggregate without external shear 
forces as described by Pizzey et al. (1989), a clear difference 
could  be  observed between  the  control  transformant and 
cells expressing NCAM, with the latter forming much larger 
aggregates (Fig. 4). Quantitative results obtained with assays 
using this procedure are summarized in Table H. Over half 
of the cells expressing wild-type NCAM were recruited into 
large aggregates, while only ,v15%  of control cells formed 
small aggregates. Cells expressing NCAMs with deletions in 
domain  1  (A1-NCAM),  domain 2  (A2-NCAM),  domain 4 
(A4-NCAM), or domain 5  (A5-NCAM) were also capable 
of forming aggregates, although to a lesser degree than intact 
NCAM transformants. Nevertheless, the percentages of cell 
aggregation elicited by these NCAM mutants were signifi- 
cantly higher than that of the control transformant. In con- 
trast,  transformants  expressing  NCAMs  with deletions  in 
domains 2  and  3  (A2,3-NCAM)  or domain  3  alone (A3- 
NCAM)  lost their  ability  to  form aggregates  completely. 
From these results, it would appear that the third Ig-like do- 
main of NCAM is particularly important in NCAM-medi- 
ated cell-cell adhesion. 
Binding of  N CAM-conjugated Covaspheres to 
Transformed L Cells 
In these studies, purified NCAM conjugated to covaspheres 
was tested for binding to cells at room temperature. Under 
these conditions, uptake of NCAM-covaspheres by L cells or 
control transformants was negligible for up to 60 rain of in- 
cubation, and binding of NCAM-covaspheres to these cells 
was minimal (Fig. 5). These results indicate that there is lit- 
The Journal of Cell Biology, Volume 118, 1992  940 l~gure 4. Aggregate formation of  L cell transformants. Transformed 
cells were collected and assayed for their ability to form aggregates 
in stiff medium at 5  ￿  106 cells/ml.  0.2-ml  aliquots were incu- 
bated at 37"C for 40 rain and then rotated up and down four times 
on a shaker. Samples were observed under the light microscope. 
(a) Cells transformed with the wild-type NCAM construct and (b) 
cells transformed  with the control  vector. Bar =  100/Lm. 
Figure 3.  Epifluorescence  micrographs  of L  cell  transforrnants. 
Transformed ceils were cultured on glass coverslips and fixed with 
methanol.  Ceils were stained with rabbit anti-NCAM antiserum. 
(a) Cells transformed  with the pEC vector; (b) cells transformed 
with the wild-type NCAM construct; and (c) ceils transformed with 
the A4-NCAM construct.  Bar =  10/~m. 
tie nonspecific attachment of covaspheres to cells. With the 
use of NCAM transformants, this assay served as a useful in 
vitro  test  for the  homophilic binding  activity of NCAM. 
When  ceils  expressing  wild-type NCAM  were examined, 
specific binding of NCAM-covaspheres could be observed 
within 10-15 min. Samples were routinely incubated for 30 
rain and  then observed by fluorescence microscopy. Con- 
tours of cells expressing NCAM were conspicuously deco- 
rated by the fluorescent spheres (Fig. 5).  This binding was 
abolished  when cells  were preincubated  with anti-NCAM 
Fab, but not with preimmune rabbit Fab. 
Cells expressing mutant NCAMs  were also assayed for 
their ability to bind NCAM-covaspheres. The result for the 
A4-NCAM transformant is shown in Fig. 5 c and is represen- 
tative of AI-, A2-, and A5-NCAM transformants (Table II). 
However, cells expressing A2,3-NCAM or A3-NCAM were 
unable to bind NCAM-covaspheres. As with the cell aggre- 
gation data,  these results  suggest that NCAM  homophilic 
binding is associated with Ig domain 3. 
Immunoreactivity of  Monoclonal Antibodies with 
NCAM Mutants 
A limitation of deletion analysis is that the three-dimensional 
structure of the protein may undergo  substantial  changes, 
and effects on the binding activity of NCAM may not be at- 
tributable to the actual deletion. Additional approaches are 
therefore  necessary  to  ascertain  results  derived  from the 
NCAM  deletion  mutants.  The  number  of  mAbs  raised 
against chicken NCAM have been found to exert either posi- 
tive or negative effects on NCAM-mediated cell adhesion 
(Watanabe et al.,  1986).  Of these,  mAbs PP and  12B  in- 
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NCAM-Covaspheres to Cells Expressing Mutant NCAMs 
Binding of NCAM-covaspheres~ 
NCAM construct  Cell aggregation*  (% positive cells) 
% 
pEC  15  +  5  9  •  1 
Wild-type NCAM  54  +  12  57  •  3 
A1-NCAM  38  •  8  43  +  13 
A2-NCAM  40  +  9  44  +  6 
A3-NCAM  13  •  8w  10  •  4 
~2,3-NCAM  13  •  29  7  +  2 
A4-NCAM  34  •  4  71  •  7 
A5-NCAM  38  •  3  46  •  7 
* Cells were dispersed and resuspended at 2  ￿  106 cells/ml. Aliquots were 
allowed to aggregate in still medium at 37~  for 40 rain and then rotated up 
and down four times before counting. Values represent the mean percentage 
of cells in aggregates +  SD of three to five experiments. 
Binding of NCAM-conjugated  covaspberes to transformed cells was carried 
out at room temperature for 20 rain as described in Materials and Methods, 
Cells with more than five eovaspheres attached on the surface were scored as 
positive cells;  results represent the mean +  SD of three  independent ex- 
periments. 
w  Results obtained with cells transformed with the A3-NCAM  or A2,3-NCAM 
construct  do not show a significant  difference  from the contoi (P > 0,05), while 
results derived from the other transforrnants  are all statistically  different from 
the control transformant, with P < 0.001. 
hibited cell adhesion,  while mAbs 9A and  11B enhanced 
adhesion.  Identification  of epitopes  recognized  by  these 
rnAbs should provide an additional method to locate sites of 
NCAM binding function. Cells expressing different mutant 
NCAM proteins were used to map the epitope locations for 
these four mAbs, using both cell panning and immunofluo- 
rescence assays. Cells were also tested against rabbit poly- 
clonal  anti-NCAM  antibodies  as  a  positive  control,  and 
against  mAb-30B  which  recognizes  the cytoplasmic  do- 
main of NCAM-180 (Watanabe et al.,  1986) as  a  nega- 
tive control.  Cells  expressing either Ag~,3-NCAM or A3- 
NCAM did not react with any of  the four anti-NCAM mAbs 
in either assay, while the other mutant NCAM proteins were 
recognized by all four mAbs (data not shown). These results 
indicate that the epitopes of  these four mAbs reside in Ig do- 
main 3. 
Mapping of the mAb PP Epitope 
Assuming that the epitopes  recognized by these four mAbs 
are in physical proximity to the homophilic  binding site in 
domain 3, it would be useful to determine their exact loca- 
tions in the protein sequence of this domain. The fact that 
these  four mAbs are able to react with denatured NCAM 
Figure 5. Binding of NCAM-conjugated covaspheres to L cell transformants. Coverslips were washed once with PBS and then incubated 
with 200/~1 of NCAM-conjugated covaspheres for 20 min at room temperature, Ceils were gently washed three times with PBS before 
observation by epifluorescence microscopy. As a control, NCAM transformants were incubated with anti-NCAM Fab (0.5 mg/ml) for 20 
min and then washed once with PBS before incubation with NCAM-covaspheres.  (a) Cells transformed  with the wild-type  NCAM eonstrnct; 
(b) eeHs transformed with the A2,3-NCAM construct; (c) cells transformed with the A4-NCAM eonstruct; and (d) cells in a  preeoated 
with anti-NCAM Fab.  Bar  =  20 #m. 
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tides. Hexapeptides were as- 
sembled on polyethylene pins 
/  as described by Geysen et al. 
D  (1987).  Pins  were incubated 
with PP-IgG (5 ~tg/ml) in mi- 
cmtiter  wells and the  relative 
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peptide analogues and the values are expressed as mean +  SD of three determinations. 
fragments in immunoblots (Watanabe et al., 1986) suggests 
that they may be able to recognize a linear sequence of  amino 
acids. To identify such sequences, the strategy of Geysen et 
al.  (1987)  was  adopted,  using  overlapping  bexapeptides 
covering the NCAM amino acid sequence from Leu-208 to 
Met-30O (Cunningham et ai., 1987).  Thus, each successive 
peptide contained the last five amino acids of the previous 
one plus the next amino acid in the sequence. These bexa- 
peptides were synthesized on plastic pins, and the binding of 
anti-NCAM mAbs to the pins was assayed by ELISA. The 
only positive signals obtained were with mAb-PP. The histo- 
gram in Fig. 6 A depicts the relative intensities of ELISA sig- 
nais  obtained  with  mAb-PP.  The  hexapeptide  sequence 
KYSFNY reproducibly reacted most strongly with mAb-PP, 
while neighboring  sequences  were only weakly reactive. 
These results thus define the boundaries of the PP epitope 
to between Lys-243 and Tyr-248. 
To determine the relative contribution of these six amino 
acids  in antibody binding,  peptide analogues with single 
amino acid substitutions were synthesized on plastic pins. 
The relative ELISA intensities obtained with these peptide 
anaiogues are shown in Fig. 6 B. Substitutions of Tyr-244, 
Phe-246,  or Tyr-248 with Ala reduced the reactivity of the 
epitope by >70 %. On the other hand, substitutions of Lys- 
243 or Ser-245  had negligible effects on antibody binding. 
Substitution of Asn-247  with Ala showed an intermediate 
effect. Interestingly, the addition of Asp-249 to the COOH 
terminus of the hexapeptide led to a twofold increase in IgG 
binding (Fig. 6 B), although the immunoreactivity of the se- 
quence YSFNYD was relatively low (Fig. 6 A). This sug- 
gests that the addition of one amino acid between Tyr-248 
and the plastic pin might have allowed the peptide to react 
more readily with the PP-IgG. 
Effects of Synthetic Peptides on the Aggregation of 
Brain Membrane Vesicles 
To determine whether the epitope of mAb-PP is actually a 
part of the homophilic binding site, oligopeptides were syn- 
thesized and tested for their ability to compete for NCAM- 
mediated adhesion. Initially, four oligopeptides (P5, P6, P7, 
and Pl0)  covering the PP epitope and/or its adjacent se- 
quences were synthesized and tested for their ability to inter- 
fete with brain membrane vesicle aggregation over assay 
periods of 3 and 6 rain. P5 contained 21 amino acids, start- 
ing with Lys-243 at its amino terminus, while P6 lacked the 
amino-terminal PP  epitope  sequence covered by P5  and 
started with Asp-249  (see Fig.  10).  Pl0 contained the se- 
quence between Lys-243 and Glu-252, while P7 contained 
a proximal sequence, spanning the sequence between Thr- 
229 and Lys-243. As a control, a peptide P5S that contained 
a scrambled P5 sequence was included in the assay. 
Chick embryonic brain membrane vesicles containing the 
high sialic acid form of NCAM aggregated rapidly at 25~ 
and this adhesion was inhibited specitically by the presence 
of Fab derived from either rabbit anti-NCAM antibodies or 
Table IlL Effect of  Synthetic Peptides on Brain Membrane Vesicle Adhesion 
Peptide  Sequence  3 min 
Aggregation of vesicles (%)* 
% inhibition  6 rain  % inhibition 
None  39  +  3 
P5  KYSFNYDGSELIIKKVDKSDE  1  +  2 
P5S  EDSKYVKIIKLYSGDENFSDK  41  +  3 
P6  DGSELIIKKVDKSDE  37  +  4 
P7  TKDGEPIEQEDNEEK  31  +  3 
P10  KYSFNYDGSE  6  +  3 
Anti-NCAM polyclonal Fab*  8  +  1 
mAb-PP Fabl  19  +  3 
-  53  +4  - 
97  0 ~: 0  100 
0  55+5  0 
5  52+5  2 
21  47 + 5  11 
85  22  +  7  58 
79  15 + 2  72 
51  29 + 2  45 
* Brain membrane vesicles from embryonic day  14 chicks were rotated at 90 rpm at 25~ 
6 rain.  In competition experiments,  peptides were added at 0.8 mg/ml.  Data are presented 
* 0.5  rng/ml Fab. 
w  0.1  mg/ml Fab. 
and the percent decrease in particle  count was determined  at 3 and 
as mean +  SD of four to eight determinations. 
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Figure 7. Dose effects of syn- 
thetic peptides on retinal cell 
aggregation.  Neural  retinal 
cells were prepared from 10- 
d-old chick embryos. Aggre- 
gation of retinal ceils was car- 
tied  out  in  the  presence  of 
different concentrations of P5 
(e), P5S (o), P10 (zx), or P6 
(A) at 37"C for 30 rain. Val- 
ues  represent  the  average of 
two to three separate assays. 
mAb-PP (Table m). Remarkably, the presence of P5 pro- 
duced an even more dramatic inhibition than either antibody, 
with an almost complete block of adhesion. P10 also was a 
potent inhibitor, although at the later assay point (6 min) its 
effectiveness  decreased to levels similar to that of  antibodies. 
In contrast, P5S, P6, and P7 had no effect at all in this assay. 
Since the only difference between P5 and P6 is the six addi- 
tional amino acids at the amino terminus of P5, it is likely 
that this amino-terminal segment of P5 harbors an NCAM 
binding site related to cell adhesion. 
Effect of Synthetic Peptides on Neural Retinal 
Cell Aggregation 
Neural  retinal  cells  from day  10  chick embryos exhibit 
NCAM-mediated  cell-cell adhesion,  which can be effec- 
tively  inhibited  by  anti-NCAM  Fab  (Rutishauser  et  al., 
1982). Whereas brain membrane vesicles contained the high 
sialic acid form of NCAM, neural retinal cells express the 
low sialic acid form. It was therefore of interest to determine 
whether P5 and PI0 could inhibit neural retinal cell reaggre- 
gation. Neural retinal cells were rotated in the presence of 
different concentrations of P5 and P10,  and both peptides 
were equally effective  in inhibiting aggregate formation, with 
50% inhibition achieved at ,~0.2 mM (Fig. 7). Effects of the 
control peptides P5S and P6 were negligible even at 1 mM. 
Control cells without peptide, as well as cells incubated with 
PSS or P6, underwent rapid reassociation, forming large ag- 
gregates within 20 rain. In contrast, aggregation of cells in- 
cubated with P5 was strongly inhibited (Fig. 8). In addition 
to P5S and P6, several additional control peptides of  different 
sizes were included in this assay. P1 and P2 were sequences 
derived from ovalbumin, while P4 contained the homophilic 
binding  site  of the  cell  adhesion  molecule gpS0  of Dic- 
tyostelium discoideum and was previously shown to be a 
potent inhibitor of gpS0  function (Kamboj  et al.,  1989). 
Although the number of cells recruited into aggregates in- 
creased gradually over time in the P5- or P10-containing 
samples,  only small aggregates were observed at 60 rain. 
Similar results were obtained with anti-NCAM Fab, except 
that the Fab had a more persistent effect than P5 (Table IV). 
On the other hand, P6, P7, and the other control peptides did 
not exert significant inhibitory effects on neural retinal cell 
adhesion (Table IV). 
The other known binding site of NCAM, associated with 
heparin binding, resides in domain 2 and is also implicated 
in  NCAM-mediated  cell  adhesion  (Cole  et  al.,  1986a; 
Frelinger and Rutishauser,  1986; Cole and Akeson,  1989). 
For comparison, neural retinal cells were also assayed for 
Figure 8. Phase micrographs showing cell aggregates formed in the 
presence of synthetic peptides. Neural retinal cells were prepared 
and aggregated as described in the legend to Fig. 7. Cell samples 
were observed under a light microscope after 30 min of rotation. 
(a) Cells aggregated in the presence of P6 (1 mg/ml), and (b) cells 
aggregated in the presence of P5 (1 mg/ml). Bar =  100/sm. 
adhesion in the presence of a  peptide (P3) that spans the 
identified heparin binding site. P3 inhibited retinal cell adhe- 
sion less effectively  than P5 or P10 (Table IV). Since P3 and 
P10 blocked two separate sites on NCAM, they were tested 
together to  determine  whether there was  any  synergistic 
effect. It was observed that P3 and Pl0 were not additive in 
their effects, with art extent of  inhibition similar to that of Pl0 
alone. 
Inhibition of  Binding of  NCAM-conjugated 
Covaspheres to Cells by Synthetic Pepffdes 
To further demonstrate that P5 and P10 indeed competed for 
the  homophilic  binding  site  on  NCAM,  the  binding  of 
NCAM-covaspheres to NCAM-transformed L cells was car- 
ried out in the presence of different peptides. P5 completely 
abolished the binding  of NCAM-covaspheres  to cells ex- 
pressing  wild-type  NCAM,  while  P6  had  no  significant 
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Aggregation of cells (%)* 
Peptide  Sequence  30 ruin  % inhibition  60 rain  % inhibition 
None  49  5:5  0  70  4-  6  0 
P1  UNFEKLTEWTSSNVMEER  47  +  2  4  65  •  2  7 
P2  ISQAVHKAHAEINE  43  +  1  12  66  •  2  6 
P3  KHKGRDVILKKDVR  32  +  6*  35  48  +  12~  31 
P4  SGYKLNVNDS  45  +  1  8  69  +  2  1 
P5  KYSFNYDGSELIIKKVDKSDE  22  +  9  55  45  +  4  36 
P5S  EDSKYVKIIKLYSGDENFSDK  53  4-  1  0  67  +  6  4 
P6  DGSELIIKKVDKSDE  53  +  4  0  69  4-  1  1 
P7  TKDGEPIEQEDNEEK  46  +  5  6  68  +  6  3 
P10  KYSFNYDGSE  24  +  7  51  46  4- 4  34 
P3  +  P10~  22  4-  3  55  42  4- 2  40 
Anti-NCAM Fablt  16  +  6  67  24 •  1  66 
* Neural retinal cells were isolated from chick day 10 embryos and reassociated in the presence of 1 mg/ml of test peptide. Samples were rotated at 150 rpm 
at 37~  and aggregation was monitored at 30 and 60 rain. Data represent the mean +  SD of 3-10 experiments. The percentage of inhibition was calculated against 
the control sample without added peptide. 
* Results using P3, P5, P10, P3  +  P10,  and anti-NCAM Fab as competitor are statistically different from the control sample (P < 0.005). 
w  Retinal cells were reassociated in the presence of both P3 (1 mg/ml) and Pl0 (0.5 mg/ml). 
II Cells were reassociated in the presence of 0.5 mg/ml of Fab derived from a rabbit antiserum directed against NCAM. 
Figure 9. Inhibition of NCAM-conjugated covasphere binding to cells. NCAM transformed cells and neural retinal ceils were assayed for 
their ability to bind NCAM-covaspheres in the presence of either P5 or P6 (1 rag/rolL Binding was carried out at room temperature for 
20 rain and coverslips were viewed by epifluorescence microscopy.  (a, b) NCAM-covasphere binding to wild-type NCAM-transtormed 
L  ceils in the presence of P5 and P6, respectively; (c, d) NCAM-covasphere binding to neural retinal cells derived from day 10 chick 
embryos in the presence of P5 and P6,  respectively. Bar  =  20/an. 
Rao et aL Homophilic Binding Domain of Neural Cell  Adhesion Molecule  945 Table V. Effect of Synthetic Peptides on the Binding of NCAM-conjugated Covaspheres to Cells 
%  cells with bound covaspheres 
Peptide  Sequence  Transformed L  cells*  Neural retinal  cells* 
None  55.3 •  6.1 
P3  KHKGRDVILKKDVR  56. I +  6.0 
P5  KYSFNYDGSELIIKKVDKSDE  1.4 •  2.2 
P5S  EDSKYVKHKLYSGDENFSDK  56.4 •  7.8 
P6  DGSELIIKKVDKSDE  52.4 •  7.9 
P7  TKDGEPIEQEDNEEK  54.5 +  5.4 
Pl0  KYSFNYDGSE  1.4  •  1.9 
46.3  +  5.8 
43.5 +  2.9 
3.0  +  2.0 
45.8 +  5.6 
41.6  + 4.8 
42.1  + 4.8 
2.1  +0.4 
* Transformed cells expressing wild-type NCAM were cultured on coverslips and incubated with NCAM-conjugated covaspheres for 30 rain at room temperature. 
Cells were observed using epifluorescence microscopy and the percentage of positive cells was estimated as described in Materials and Methods. Values represent 
the mean •  SD of three experiments. 
$ Neural retinal cells were isolated from chick day 10 embryos, attached to coverslips, and then assayed for covasphere binding. Values represent the mean •  SD 
of three experiments. 
effects (Fig.  9).  Similar  results were obtained with trans- 
formed ceils expressing A4-NCAM (data not shown). When 
the shorter peptide P10 was examined, it was again found to 
be a potent inhibitor and the binding of NCAM-covaspheres 
to cells was reduced to background level. The control pep- 
tides PSS and P7 did not affect covasphere binding (Table V). 
Thus the binding site identified in the ceil aggregation studies 
also appears to be required for NCAM-NCAM binding. In- 
terestingly, P3, which contains the heparin binding domain, 
had little effect in this assay. Thus, in this assay the heparin 
binding  site  does not appear to be necessary for NCAM 
homophilic binding. 
Similar results were obtained when the same experiments 
were carried out using NCAM-covaspheres and retinal cells 
(Fig. 9 and Table V). Both P5 and PI0 inhibited the binding 
of NCAM-covaspheres to retinal cells. P3 and the other con- 
trol  peptides  failed  to  exert  negative  effects  on  NCAM- 
covasphere binding to cells. 
Attachment of Neural Retinal Cells to 
Peptide Substrates 
While  P10  clearly delineates  an  NCAM binding  site,  the 
question  remains as  to whether  it participates directly  in 
homophilic binding. To test this possibility, the binding ac- 
tivity of synthetic peptides was investigated using a  cell- 
substratum adhesion assay. Peptides P5 and P11 were conju- 
gated to KLH using EDC and MBS,  respectively, and ad- 
sorbed to nitrocellulose-coated Petri dishes. P11 (CEKYSE- 
NYDGSE)  overlaps  with  P10,  spanning  the  sequence 
between Glu-242 and Glu-252, with an additional Cys resi- 
due added at its amino terminus for the purpose of conju- 
gation.  Neural retinal  cells labeled with  [3H]leucine were 
placed in these dishes and assayed for attachment to the sub- 
stratum. Over 60% of input cells attached to the immobi- 
lized PS-KLH or Pll-KLH (Fig.  10).  In contrast, immobi- 
lized KLH alone or P6-KLH gave <10 % attachment of input 
cells. 
The specificity of the substrate attachment activity of P5 
and P11 was further supported by competition studies using 
free peptides. In both cases, attachment of retinal ceils to the 
peptide substrates was reduced to background levels by P5 
or P10, while P6 had no effect (Fig.  10).  To demonstrate the 
involvement of NCAM,  retinal  cells were precoated with 
anti-NCAM Fab before the attachment assay. Attachment of 
these cells to P5-KLH or Pll-KLH substratum was greatly 
reduced (Fig.  10),  indicating that the attachment of retinal 
cells to the dish was dependent on the interaction of NCAM 
with either P5 or P11. 
Discussion 
These experiments have led to the identification of an amino 
acid  sequence  in  NCAM  that  is  capable  of  mediating 
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Figure 10. Binding of neural retinal ceils to peptide-KLH conju- 
gates. Neural retinal ceils were prepared from 10-d-old chick em- 
bryos and then metabolically labeled with pH]leucine (25 uCi/ml) 
for 2 h at 37~  in a leucine-free medium. Petri dishes were coated 
with nitrocellulose  solubilized in methanol.  Aliquots of peptide- 
KLH conjugates were placed on marked spots on the plastic surface 
and allowed to adsorb to the nitrocellulose for 1.5 h. Cells (50 ~1) 
were placed on these spots and incubated for 2 h at 37~  In compe- 
tition studies, 25-#1 aliquots of P5 or PlO (2 mg/ml) were placed 
on these spots for 5 rain and then 25 #1 of cells, containing  ~3.5 
x  liY cells, was placed on each spot.  Alternatively, retinal cells 
were precoated with anti-NCAM Fab (0.5 mg/ml) for 30 rain. After 
washing once to remove unbound Fab, cells were deposited on the 
Petri dish for the attachment  assay. At the end of the incubation 
period,  unbound cells were gently removed by rinsing the dishes 
with PBS. The amount of bound cells was estimated by solubflizing 
the cells on each spot with SDS and then counting in a scintillation 
counter. The data represent the mean of four experiments. 












l~gure 11. Alignment of the chick 
NCAM homophilic binding site 
with sequences of other species. 
The  Ig-like domain 3 sequence 
(from  Cys-216  to Cys-268)  of  chick 
NCAM (Hemperley et al., 1986; 
Cunningham et  al.,  1987) was 
aligned  with sequences  of  the same 
region from Xenopus (Krieg et al., 1989), human (Dickson et al., 1987), rat (Small et al., 1987), and mouse (Barthels et al., 1987). The 
chick decapeptide sequence involved in homophilic interaction and identical residues present in the other vertebrate NCAM sequences 
are shown in bold type. The solid lines represent the position of the peptide sequences for PS, Pt, 1'7, and P10. 
involved the construction of a series of NCAM deletion mu- 
tants for transfection into noncohesive mouse L cells. Quan- 
titative cell reaggregation assays indicated that a high per- 
centage of  cells expressing the wild-type form of  NCAM-140 
were capable of forming large aggregates in the absence of 
shear forces, consistent with a homophilic adhesion mecha- 
nism. Transformants expressing A2,3-NCAM or A3-NCAM 
were unable to form aggregates, suggesting that sequences 
within domain 3 are intimately involved in the adhesion pro- 
cess. In contrast, transformants expressing NCAM mutants 
with domains 1, 2, 4, or 5 deleted were capable of aggrega- 
tion, indicating that these four domains are less important in 
homophilic interactions. Similarly, the specific binding of 
NCAM-covaspheres to NCAM-transformed cells was also 
found to be dependent on the presence of domain 3, as only 
transformants expressing  A2,3-NCAM  or A3-NCAM lost 
their  ability to bind NCAM-covaspheres.  Together,  these 
results provide strong evidence that a  homophilic binding 
site is present in Ig domain 3 of NCAM. 
Cells expressing A4- or A5-NCAM did demonstrate some- 
what lower levels of adhesion than the intact molecule. As 
NCAM-NCAM dimers appear  to involve extended mole- 
cules with a hingelike structure (Hall and Rutishauser, 1987; 
Becket et al., 1989),  the deletion of segments distal to do- 
main 3 could shorten the distance of the homophilic binding 
site from the plasma membrane, rendering it less accessible 
to NCAM on adjacent cells. The deletion of either domain 
1 or 2 also had only a small negative effect on cell aggrega- 
tion, despite the fact that the heparin binding site in domain 
2 is thought to contribute to the stability of NCAM-medi- 
ated cell-cell adhesion (Cole et al.,  1986a;  Frelinger and 
Rutishauser, 1986; Reyes et al., 1990).  Moreover, the dele- 
tion of domain 2 did not have a significant effect on the bind- 
ing of NCAM-covaspheres to cells expressing this mutant 
NCAM, and the binding of covaspheres to cells expressing 
wild-type NCAM was not affected by the peptide P3, which 
contains the heparin binding domain. These results suggest 
that our transfected cell model lacks the competence to ex- 
hibit the effects of heparan sulfate on NCAM binding, possi- 
bly because L cells do not express the appropriate type or 
amount of heparan sulfate. Such a deficit could well explain 
why aggregation of NCAM-transformed cells is much more 
sensitive to shear forces than retinal cells. In any case, our re- 
sults suggest that NCAM-NCAM binding can occur through 
domain 3 to domain 3 interactions. 
Our second approach  was to map the epitopes of four 
mAbs that have been shown to affect NCAM-mediated adhe- 
sion (Watanabe et al., 1986).  All four of the mAb epitopes 
have been mapped to domain 3, consistent with the previous 
report that these sites lie between the heparin binding do- 
main  and  the  glycosylation  sites  of  domains  4  and  5 
(Frelinger and Rutishauser,  1986).  These mAbs were as- 
sayed against a series of overlapping hexapeptides assembled 
on plastic pins in order to map their respective epitopes. 
mAb-PP was the only one that recognized a linear hexapep- 
tide sequence,  reacting  strongly with the sequence KYS- 
FNY. The specificity of this epitope is further supported by 
the finding that substitution of any one of the three aromatic 
amino acids with Ala drastically diminishes its reactivity 
with mAb-PP. These results also suggest that aromatic inter- 
actions (Burley and Petsko, 1985),  as well as the formation 
of hydrogen bonds, may be important for PP binding to its 
epitope. 
The ability of mAb-PP to inhibit NCAM-mediated cell- 
cell adhesion suggests that its epitope is part of or in prox- 
imity to the homophilic binding site. Indeed, synthetic oligo- 
peptides containing the PP-epitope exhibit strong inhibitory 
effects on NCAM activity in several in vitro assays. The ob- 
servation that the neighboring sequence (P6) was not inhibi- 
tory further demonstrates that the PP epitope forms an inte- 
gral part of the homophilic binding site. The shorter active 
peptide sequence within P5 is that of Pl0, with its first six 
amino acids constituting part of the PP epitope. Pl0 was just 
as effective as p5 in inhibiting retinal cell aggregation and the 
binding of NCAM-covaspheres to  retinal cells or NCAM 
transformants. However, it should be noted that Pl0 was less 
potent in the membrane vesicle assay,  particularly during 
later times in the assay, consistent with a lower affinity than 
P5 for NCAM. Also, the efficacy of these peptides seems to 
vary somewhat between the vesicle assay and the retinal cell 
aggregation assay.  The reason for this is not clear, but it 
could reflect differences in the components present on the 
membrane surface, the different forms of NCAM expressed 
in brain and retinal cells, or differences in assay conditions, 
such as shear force. Nevertheless, both P5  and Pl0 show 
consistent inhibitory effects  in all three assays.  Together, 
these findings further narrow down the active region to the 
decapeptide sequence KYSFNYDGSE. 
A simple cell-substratum adhesion assay has been used to 
confirm the  biological activity of the  synthetic peptides. 
When  either  PS-KLH or  Pll-KLH  was  immobilized on 
nitrocellulose coated dishes, retinal cells attached efficiently 
to these surfaces. This cell-substratum interaction appeared 
to be highly specific since retinal cells did not attach to KLH 
or P6-KLH. Cell attachment to P5-KLH and Pl 1-KLH was 
also inhibited by free P5 or Pl0 peptides, but not by P6. Bind- 
ing of anti-NCAM Fab to cells before the assay blocked cell 
attachment to these peptide conjugates, indicating that the 
peptides were interacting directly with NCAM on the cell 
surface. 
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the first five Ig-like domains exhibit a very high degree of se- 
quence homology among chick, human, rat,  and mouse, 
with >80% sequence identity. Surprisingly, the chick homo- 
philic binding site is one of the few less conserved regions 
(Fig.  11). The decapeptide sequence shows 70%  sequence 
identity with the same region in Xenopus NCAM, but only 
50 % sequence identity with human, mouse, and rat NCAM. 
On the other hand, the mouse and rat sequences are identical 
and show 80% sequence identity  with the human sequence. 
All five  species  share  four  common amino acid residues  at 
this  site:  Lys-243, Phe-246, Asp-249, and Ser-251. The se- 
quence divergence and the  presence of  three  aromatic amino 
acid  residues  in  this  region probably contribute  to its  antigc- 
nicity  and thus  the success of our immunological approach 
in  identifying  it  as a homophilic binding site.  Our results  do 
not preclude the contribution  of  other sequences within the 
more conserved regions  of  domain 3 to  homophilic binding. 
However, it is evident that  perturbation of binding that  in- 
volves  the KYSFNYDGSE  sequence is sufficient  to disrupt 
homophilic interaction. 
The implication of the sequence  divergence is not yet 
clear,  but it  could account for  species  differences  in  NCAM- 
mediated adhesion. That is,  the  binding of  brain membrane 
vesicles from different  species to a layer  of chick retinal 
cells, while always inhibited  by anti-chick  NCAM  Fab, is 
quantitatively less  efficient  than the chick-chick combina- 
tion (Hall and Rutishauscr, 1985). That chick NCAM  can 
bind at all to mouse NCAM  possibly reflects  the fact  that 
other  sites,  such  as  the  domain 2 heparin  binding  region,  also 
support interaction.  Moreover, as discussed below, certain 
key features  of the homophilic binding site  may be highly 
conserved among all species. 
A salient  feature  of  the chick NCAM  homophilic binding 
site is the  alternation of hydrophilic and  hydrophobic 
residues, which is typical of a/3-sheet structure. Secondary 
structure predictions also show that this region has a high 
probability for/3-sheet structure, with its carboxyl-terminal 
residues adopting a/3-turn (Chou and Fasman,  1978).  By 
analogy with the known crystal structure of Ig domains, this 
region corresponds to the C' strand of the ~3-barrel structure 
(Santoni et al., 1988; Williams and Barclay, 1988). Since the 
homophilic binding site is rich in terms of polar and charged 
residues, it may be exposed on the surface of the molecule, 
thus facilitating interactions with other NCAM molecules. 
While this sequence shows little structural resemblance to 
the  HAV-contalning  cell  adhesion  sequence  of cadherins 
(Blaschuk et al., 1990),  it appears to share some structural 
features with the homophilic binding site of gp80,  a  cell 
adhesion  molecule  known  to  mediate  Ca2+-independent 
cell-cell adhesion in Dictyostelium discoideum (Siu et al., 
1985,  1987; Kamboj et al.,  1988).  gp80 shows limited se- 
quence and structural similarities with NCAM and Ig, sug- 
gesting that it may also belong to the Ig superfarnily (Mat- 
sunaga and Mori, 1987; Siu and Kamboj, 1990).  The gpS0 
homophilic binding site consists of the octapeptide sequence 
YKLNVNDS, which is also predicted to assume a/3-sheet 
conformation  (Kamboj  et  al.,  1989).  The  two  charged 
residues (Lys and Asp) have been shown to play a vital role 
in the initial electrostatic interactions between two apposing 
gp80 molecules, and it is of interest to speculate that the 
charged residues at similar positions (Lys-243 and Asp-249) 
in the NCAM homophilic binding site may also play a central 
role. That these two charged residues are among the four 
amino acids that remain invariant in the five vertebrate spe- 
cies (Fig.  11) is also consistent with a key role for them in 
homophilic binding.  Thus,  despite  the divergence in  se- 
quence among the species discussed above, some potentially 
critical features of the binding site appear to be conserved. 
Our studies suggest a domain 3 to domain 3 interaction in 
NCAM-NCAM binding, which appears to be independent of 
other molecular interactions. However,  our results are also 
consistent with an auxiliary but independent role for a hepa- 
rin binding site in domain 2. The interactions centered at the 
homophilic  binding  site  may  represent  the  first  step  of 
NCAM-NCAM binding, leading to conformational changes 
and molecular interactions involving other parts of NCAM 
and possibly with other molecules as well (Cole and Akeson, 
1989;  Kadmon et al.,  1990). 
Our data cannot distinguish between a parallel or anti- 
parallel alignment of the third domains of two molecules on 
apposing surfaces. A more detailed analysis will be required 
to determine the location of the binding site for the KYSF- 
NYDGSE  sequence  and,  in  particular,  whether  this  se- 
quence binds with the identical sequence or with a different 
site in domain 3. In the case of the Dictyostelium cell adhe- 
sion molecule gp80,  there is evidence that its homophilic 
binding site interacts in an anti-parallel manner with the 
same sequence of another gp80 molecule (Kamboj et al., 
1989).  Should it be the same for NCAM, it is conceivable 
that the aromatic side-chains of Tyr-244, Phe-246,  and Tyr- 
248 may undergo stacking (Burley and Petsko,  1985), which 
would  in  turn  further  stabilize  the  interactions  between 
NCAM molecules on apposing surfaces. 
Finally, it must be emphasized that NCAM is a large multi- 
domain, multi-function structure, apparently capable of bet- 
erophilic as well as homophilic interactions, and of attenuat- 
ing as well as promoting cell-cell interactions. Thus, while 
delineation of the domain 3 binding site is an important ad- 
vance in defining the homophilic binding properties of the 
molecule, much additional study will be required to under- 
stand its full role at the cell surface. 
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